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Drosophila Dscam Is an Axon Guidance Receptor
Exhibiting Extraordinary Molecular Diversity
modified by neuronal activity (reviewed by Albright et
al., 2000).
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guidance signals and their receptors. These signals mayand S. Lawrence Zipursky*³
be secreted or membrane-bound and they can attract*Howard Hughes Medical Institute
or repel growth cones (Tessier-Lavigne and Goodman,Department of Biological Chemistry
1996; Culotti and Merz, 1998; Guthrie, 1999). The re-UCLA School of Medicine
sponse of a growth cone to specific signals is deter-675 Charles E. Young Dr. South
mined by the receptors on its surface and the activityLos Angeles, California 90095
of signaling pathways acting within the growth cone²University of Michigan
(Ming et al., 1997; Bashaw and Goodman, 1999; HongDepartment of Biological Chemistry
et al., 1999). Connection specificity requires growth1301 E. Catherine
cones to respond to different levels of the same signalAnn Arbor, Michigan 48109
(Flanagan and Vanderhaeghen, 1998) and combinations
of different signals (Winberg et al., 1998), to integrate
this information, and to translate it into changes in motil-
Summary ity (Suter and Forscher, 1998). While it is clear that these
events must ultimately converge on the actin-based cy-
A Drosophila homolog of human Down syndrome cell toskeleton of the motility apparatus in the growth cone,
adhesion molecule (DSCAM), an immunoglobulin su- the biochemical mechanisms by which this occurs are
perfamily member, was isolated by its affinity to Dock, not well understood.
an SH3/SH2 adaptor protein required for axon guid- To gain insight into the mechanisms by which growth
ance. Dscam binds directly to both Dock's SH2 and cones integrate guidance cues, we pursued a combined
SH3 domains. Genetic studies revealed that Dscam, biochemical and genetic analysis of the Dock signal
Dock and Pak, a serine/threonine kinase, act together transduction pathway. Dock is an adaptor protein con-
to direct pathfinding of Bolwig's nerve, containing a taining 3 SH3 domains and a single SH2 domain, and
subclass of sensory axons, to an intermediate target is closely related to mammalian Nck (Clemens et al.,
in the embryo. Dscam also is required for the formation 1996; Garrity et al., 1996; Rao and Zipursky, 1998). dock
of axon pathways in the embryonic central nervous mutants show defects in axon guidance in the adult fly
system. cDNA and genomic analyses reveal the exis- visual system (Garrity et al., 1996) and in the embryonic
tence of multiple forms of Dscam with a conserved nervous system (Desai et al., 1999). Based on the role
architecture containing variable Ig and transmem- of the adaptor protein Grb-2 in linking receptor tyrosine
brane domains. Alternative splicing can potentially kinases to Ras (Olivier et al., 1993), we proposed that
generate more than 38,000 Dscam isoforms. This mo- Dock links guidance receptors to downstream regula-
lecular diversity may contribute to the specificity of tors of the actin cytoskeleton. We previously demon-
neuronal connectivity. strated that Pak, a p21-activated serine/threonine ki-
nase, acts downstream of Dock in adult photoreceptor
neurons (Hing et al., 1999). Dock binds through its sec-Introduction
ond SH3 domain to Pak and Pak binds directly to Rho
family GTPases (Manser et al., 1994), evolutionarilyClassical embryological, genetic, and biochemical ap-
conserved regulators of the actin-based cytoskeletonproaches have led to important insights into the mecha-
(Nobes and Hall, 1995; Hall, 1998). Genetic studies re-nisms by which neurons form connections during devel-
vealed that both Pak's kinase activity and its interactionopment (Lance-Jones and Landmesser, 1981; Thomas
with Rho family GTPases are essential for axon guidanceet al., 1984; Goodman and Shatz, 1993). In both verte-
(Hing et al., 1999).brates and invertebrates, axon pathways are estab-
In this paper, we describe a novel guidance receptorlished in a stepwise fashion. The growth cone, a sensori-
that is highly related to a human protein called Downmotor structure at the leading edge of the extending
syndrome cell adhesion molecule (Yamakawa et al.,
axon, detects specific signals and translates them into
1998; see Discussion). Drosophila Dscam was identified
directed movement (Lin and Forscher, 1993; Tanaka and
in a novel screen for proteins interacting with the Dock
Sabry, 1995). Growth cones migrate through complex SH2 domain. Dscam binds directly to multiple domains
cellular environments by responding to specific guid- of Dock and is widely expressed on axons in the embry-
ance cues produced by cells along their trajectories. onic nervous system. To gain insight into the mechanism
Once in the target region, growth cones stop, select by which Dscam, Dock, and Pak function in growth
specific targets, and form synapses. In some regions cones, we focused on their roles at a single guidance
of the nervous system, these connections are further step in the simple axon trajectory of Bolwig's nerve (BN)
in the embryo. We show that Dscam is required for
recognition of an intermediate targeting determinant for³ To whom correspondence should be addressed (e-mail: zipursky@
the BN, that Dock and Pak are required for this step,hhmi.ucla.edu [S. L. Z.], jedixon@umich.edu [J. E. D.]).
§ These authors contributed equally to this work. and that Dscam shows dosage-sensitive interactions
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with both dock and Pak. Based on these studies, we
propose that Dscam recognizes a guidance signal(s)
and translates it into changes in the actin-based cy-
toskeleton through Dock and Pak.
In the course of the analysis of Dscam cDNAs, we
uncovered extraordinary sequence diversity in the extra-
cellular region. Through splicing of alternative exons
encoding three different Ig domains and the transmem-
brane domain, more than 38,000 proteins may be gener-
ated. These proteins would have an identical architec-
ture but differ in their combination of the four variable
domains. We also show that Dscam is required in other
neurons in the developing central nervous system for
the establishment of axon pathways. This raises the
intriguing possibility that diverse forms of a single pro-
tein may contribute to specifying the precise connec-
tions made by many different types of neurons.
Results
Identification of Dscam as a
Dock-Interacting Protein
We reasoned that the Dock SH2 domain could be used
as an affinity reagent to purify upstream guidance recep-
tors in the Dock signaling pathway. Two tyrosine-phos-
phorylated proteins, p145 and p270, were detected in
Dock immunoprecipitates of S2 cell extracts (Clemens
et al., 1996). To obtain a source of cells from which to
purify sufficient quantities of these proteins for micro-
sequencing, we created an S2 cell line, S2HisSH2, in which
a histidine-tagged Dock SH2 domain (Figure 1A) was
constitutively expressed. A dramatic increase in the
level of phosphotyrosine in p145 and p270 was observed
which may reflect protection from endogenous phos-
phatases by binding to the excess Dock-SH2 domain
expressed in these cells (Figures 1B and 1C).
As a first step to purifying proteins associated with
the Dock-SH2 domain, lysates prepared from S2HisSH2
cells were subjected to Ni-agarose affinity chromatogra-
Figure 1. Identification and Isolation of Dock SH2 Domain±Asso-
phy (see Experimental Procedures). Tyrosine phosphor- ciated Proteins
ylated proteins corresponding to p145 and p270 copuri-
(A) Schematic representation of Dock and the SH2 domain of Dock
fied with the SH2 domain (compare Figures 1B and 1C). modified with six tandemly arranged histidine residues at its N termi-
In addition, several other tyrosine-phosphorylated pro- nus (HisSH2).
(B) Tyrosine-phosphorylated (pTyr) proteins associated with Dock.teins, not previously detected in Dock immunoprecipi-
Dock immunoprecitates from S2 cells were Western blotted withtates, copurified (Figure 1D). These proteins were bound
anti-phosphotyrosine antibody 4G10. Control is from immunopre-to a P-Tyr-specific antibody affinity column, eluted, and
cipitates using preimmune serum.separated by SDS-PAGE electrophoresis. Coomassie-
(C) Dock SH2 domain±associated proteins. pTyr-containing proteins
stained proteins with molecular weights of 270, 145, 74, from S2 cell extracts that express HisSH2 (S2HisSH2) or vector controls
69, and 63 kDa were observed (Figure 1D). Here we (S2) were detected as in (B). The band labeled with an asterisk is
of similar size to p270 and is of unknown identity. The X-ray filmfocus on a biochemical and genetic analysis of p270.
exposure time was 10-fold less in (C) than (B), indicating a strongDetailed characterizations of the other proteins will be
enhancement of tyrosine phosphorylation of these proteins.described elsewhere.
(D) Purification of pTyr-containing proteins. pTyr-containing pro-To obtain amino acid sequences of p270, the band
teins were purified from S2HisSH2 by sequential binding to Ni-agarose
was excised from the Coomassie-stained gel and di- and 4G10 affinity columns. Bound fractions from these columns are
gested with trypsin. Tryptic peptides were eluted and shown as indicated. As a final step in purification, proteins were
separated by SDS-PAGE and identified by Coomassie stain. p74 isseven peptide sequences were determined. Two ex-
not visible as a Coomassie-stained band in this figure, but is visiblepressed sequence tags (ESTs) were identified that en-
in the pTyr blot in the Ni-agarose eluate. p69 is visible in the Coomas-coded all seven peptides. A 7,754 bp contig was assem-
sie-stained gel, but does not correspond to any pTyr-containingbled from ESTs and 59 RACE products. This cDNA size
bands. Presumably this band is associated with a pTyr-containing
is consistent with the 8 kb mRNA observed by Northern protein that associates with the SH2 domain. Bands were excised,
blot analysis (data not shown). The cDNA contains an trypsin-treated, and microsequenced (see Results and Experimental
Procedures).open reading frame of 6,048 nucleotides encoding from
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Figure 2. p270 Is Drosophila Dscam
(A) The amino acid sequence of p270. p270 is a
single pass transmembrane protein containing
multiple domains. These are color-coded as
indicated. The amino acid sequences ob-
tained for the p270 tryptic peptides are under-
lined. Two 33 amino acid direct repeats each
contain a single Dock SH2-domain consen-
sus binding site (YDDP). The PXXP motifs are
numbered.
(B) The domain structures of p270 and human
DSCAM are compared. Numbers between
the schematics indicate percent identities be-
tween the compared domains. Based on the
similarities in domain structure and amino
acid sequence, we refer to p270, henceforth,
as Drosophila Dscam (see text).
its N terminus as predicted from SMART analysis and human proteins are identical. They share 32% se-
quence identity and 49% sequence similarity (Figure 2).(Schultz et al., 2000) (Figure 2): (1) a putative signal
peptide; (2) nine tandemly repeated immunoglobulin (Ig) In contrast, the intracellular domains appear unrelated
(see Discussion). Based on the similarities in the extra-domains; (3) four fibronectin type III (FNIII) domains; (4)
a single Ig domain; (5) an additional two FNIII domains; cellular domain, we refer to p270 as Drosophila Dscam.
Two lines of evidence indicate that p270 is Dscam(6) a transmembrane domain; and (7) a novel cyto-
plasmic domain of 374 amino acids containing multiple (Figure 3A): (1) tyrosine phosphorylated p270 is depleted
from S2 cells treated with Dscam double-stranded RNApotential tyrosine phosphorylation sites and several pu-
tative SH3 binding sites. Interestingly, two 33 amino (RNAi) (for use of RNAi in Drosophila S2 cells, see Clem-
ens et al., 2000); (2) anti-Dscam antibody recognizes aacid repeats are found in the cytoplasmic domain each
containing a consensus Dock/Nck SH2 binding motif band at 270 kDa that is missing in Dscam RNAi-treated
S2 cells. Dscam is detected in Dock immunoprecipitates(Song et al., 1998; Stein et al., 1998).
The extracellular region of p270 contains Ig and FNIII prepared from embryonic extracts (Figure 3B), where it
also appears to be tyrosine phosphorylated. A seconddomains that are frequently found in axon guidance re-
ceptors, including Robo (Kidd et al., 1998) and the netrin- band, not seen in S2 cells, migrating at 220 kDa was
detected by anti-Dscam and anti-pTyr. This may repre-receptor Frazzled (Kolodziej et al., 1996). p270 is most
highly related to human DSCAM, a gene that has been sent a cross-reactive protein. Alternatively, as the pre-
dicted molecular weight of Dscam after cleavage of theimplicated in the mental retardation associated with
Down syndrome (Yamakawa et al., 1998). The number signal peptide is 219 kDa, this may reflect differences
in posttranslational modification of Dscam.and organization of the extracellular domains of the fly
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Figure 3. Dscam Binds to the SH2 and SH3 Domains of Dock
(A) Dscam is p270. The HisSH2 domain was purified from S2HisSH2 cells (untreated) or S2HisSH2 cells grown in the presence of Dscam double-
stranded RNA (RNAi). HisSH2 domain±associated proteins were analyzed by immunoblotting with pTyr or Dscam antibodies as indicated.
Tyrosine-phosphorylated p270 is greatly diminished in the Dscam RNAi lane while p145 is unaffected. Dscam immunoreactivity is not detected
in Dscam RNAi cells.
(B) Dscam is associated with Dock in embryo extracts. Dock immunoprecipitates from 12±18 hr embryo extracts were analyzed by blotting
with pTyr or Dscam antibodies as indicated. In addition to Dscam, which migrates at 270 kDa, a second band of 220 kDa is observed. The
difference in size may reflect a posttranslational modification. Alternatively, p220 may be a cross-reactive band. The 270 kDa band is more
heavily tyrosine phosphorylated as shown in the anti-pTyr blot.
(C) Dock SH2 directly binds Dscam. Dock immunoprecipitates from untreated or Dscam RNAi±treated S2 cells were probed with radiolabeled
Dock SH2 domain. A band corresponding to Dscam was depleted by Dscam RNAi treatment. SH2 binding to p145 was detected in both
lanes.
(D) Dock SH3 domains bind Dscam in yeast. Full-length Dock and individual SH3 domains fused to LexA were tested for interaction with wild-
type or mutant Dscam cytoplasmic domains fused to Gal4 activation domain. The two PXXP sites and the polyproline motifs are represented
by shaded and black boxes, respectively. Mutations in the PXXP motifs are indicated by Xs. The relative strengths of the interactions are
represented by using ª1º and ª2º (see Experimental Procedures).
(E) Dock SH3 domains bind to Dscam in vitro. GST fused to the three SH3 (3SH3) domains together or each SH3 domain separately were
tested for binding to wild-type and mutant forms of the cytoplasmic domain of Dscam synthesized in vitro (see Experimental Procedures). In
addition to the forms of Dscam analyzed in (D), binding to a C-terminal fragment containing the polyproline motif also was tested.
The Cytoplasmic Domain of Dscam Interacts The SH3 domains of Dock also directly interact with
Dscam. Interactions between different SH3 domains andwith Multiple Domains in Dock
We previously proposed that Dock interacts with up- Dscam were assessed in a yeast two-hybrid assay and
in GST pulldown experiments. In yeast, full-length Dockstream guidance signals in a redundant fashion through
both SH3 and SH2 domains based on mutational analy- interacts strongly with the cytoplasmic domain of
Dscam (Figure 3D). Each of the three SH3 domainsses of domain requirements for Dock in axon guidance
(Rao and Zipursky, 1998). The Dock SH2 domain inter- tested individually in yeast showed reduced interaction.
The SH3 domains also were shown to interact with theacts directly with Dscam as shown in a GST-SH2 domain
gel overlay experiment (Figure 3C). Dock immunoprecip- cytoplasmic domain of Dscam in GST pulldown experi-
ments (Figure 3E). Dscam was bound by GST fuseditates from S2 cells were separated on an SDS polyacryl-
amide gel and blotted with 32P-labeled Dock SH2 do- to the three SH3 domains (GST-3-SH3). While Dscam
bound to each SH3 domain fused separately to GST,main. A tyrosine-phosphorylated band comigrating with
Dscam bound to the radiolabeled probe (Figure 3C). the fraction bound was considerably reduced when
compared to GST-3-SH3. The amounts of GST fusionBinding was disrupted by pretreatment with alkaline
phosphatase (data not shown). That this band corre- proteins used in these experiments were similar. This
suggests Dock interacts through multiple SH3 domainssponds to Dscam is supported by the finding that it was
missing in extracts prepared from S2 cells depleted of with Dscam.
The interaction sites between different SH3 domainsDscam by RNAi.
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portion of the Dscam cytoplasmic domain; a C-terminal
polyproline sequence (PEPPP) also was found. Site-
directed mutagenesis of the PXXP sites revealed that
the first SH3 domain (SH3-1) binds preferentially to
PXXP1 and third SH3 domain (SH3±3) to PXXP2 (see
Figures 3D and 3E). GST-SH3-1 and GST-SH3-3 interact
with the N-terminal half of the cytoplasmic tail of Dscam
containing the PXXP sites, but only weakly to the C-ter-
minal half encompassing the polyproline sequence.
Conversely, the second SH3 domain (SH3-2) binds
preferentially to the C-terminal polyproline motif. That
PXXP1 and PXXP2 sequences are the primary interac-
tion sites between Dock and Dscam is strongly sup-
ported by the marked reduction in interaction between
Dock and the cytoplasmic domain of Dscam carrying
point mutations in both these sites. Residual binding
may be due to interaction between SH3-2 and the
C-terminal polyproline sequence (Figure 3E). In sum-
mary, these data indicate that Dscam binds directly to
Dock through both SH3 and SH2 domains, consistent
with genetic studies arguing for redundancy between
these domains.
Identification of Dscam Mutants
To critically assess whether Dscam is required for axon
guidance, we sought to identify loss-of-function muta-
tions. Dscam was localized to region 43B1-B3 by in situ
hybridization to salivary gland polytene chromosomes.
Four lethal complementation groups were previously
mapped to this region by Heitzler et al. (1993) (Figure
4A). Sequences abutting a P element lethal insertion
into one of these complementation groups, l(2)43Bc,
were identical to sequences in a P1 genomic clone con-
taining Dscam sequences. This insertion mapped 1200
nucleotides downstream from exon 4.1 (see section be-
low and Figure 7 for genomic organization); exon 4 en-
codes part of the second Ig domain (Figure 4B). Two
inversion alleles of l(2)43Bc also break within the Dscam
locus. In(LR)43b71kIA breaks in the 8.8 kb intron sepa-
rating exons 2 and 3 (Figure 4B). A second inversion,
In(2R)DX8, also breaks within the Dscam locus, although
the precise breakpoint was not identified. A single EMS
allele, l(2)43Bc1, fails to complement the inversions
and the P allele. All alleles were early larval lethal. We
have renamed them as follows: l(2)43Bc1 5 DscamE1;
In(LR)43b71kIA 5 DscamX1; In(2R)Dx8 5 DscamX2; and
Figure 4. Dscam Protein Is Not Detected in Dscam Mutant Embryos the P allele 5 Dscamp.
(A) Dscam maps to 43B1-4. Small chromosomal deficiencies in the To assess the effect of these mutations on Dscam
43B region are shown. Gaps correspond to deleted DNA. protein expression, mutant embryos were stained with
(B) DscamP is caused by P element insertion P05518. Sequence an antibody generated to an N-terminal peptide ofanalysis revealed that the P element is located downstream of exon
Dscam. In wild type, Dscam staining is largely confined4.1 (see Figure 8A). DscamX1 breaks between exons 2 and 3. Exon
to axons in stage 16 embryos. Staining is most promi-2 contains the start ATG and part of the signal peptide.
(C±H) Dscam is expressed on axons in the embryonic CNS. (C) nent in the connectives and the commissures (Figures
Schematics of CNS axon tracts. (D) Lateral view of anti-Dscam 4C±4H). Dscam immunoreactivity was not detected in
stained embryo. Staining is confined to the axon layer. (E and F) embryos homozygous for any of these alleles. The highly
Axon tracts in Dscam heterozygotes stained with anti-Dscam (ar- restricted expression of Dscam to axons suggested thatrowheads). (G and H) No Dscam immunoreactivity is seen in homo-
it might play a direct role in axon guidance.zygous Dscam embryos. As an internal control for staining, both
homozygous and heterozygous embryos were costained with anti-
Krueppel, a marker for a subset of neuronal nuclei (arrows). Axon Pathways in the Central Nervous System
Are Disrupted in Dscam Mutants
As Dscam mutants are early larval lethal and Dscam isand Dscam were mapped (Figures 3D and 3E). Two
expressed on many axons in the developing embryonicputative SH3 binding sites (PXXP1 and PXXP2) sepa-
rated by 40 amino acids were found in the N-terminal CNS, we set out to assess whether mutations in Dscam
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ance. The projection of BN elaborates a simple and
well-studied pathway (Schmucker et al., 1997). Bolwig's
organ, a larval photosensitive structure, contains 12
photoreceptor neurons that extend a single bundle of
axons during embryogenesis to their targets in the brain.
BN extends posteriorly along the embryonic optic stalk
to the surface of the optic lobe (see Schmucker et al.,
1997). It then grows across the surface of the optic lobe
to a presumptive intermediate target neuron, P2. At P2,
the growth cones pause before projecting to their synap-
tic targets in the brain (see schematic in Figure 6). Phe-
notypes can be readily assessed in embryos double-
stained for BN and P2, using mAb22C10 and anti-Bsh
(brain-specific homeobox protein), respectively (Fig-
ure 6).
In stage 16 embryos carrying DscamE1 or DscamP over
a deficiency, some 53%±58% of BN projections were
defective (n 5 349; Table 1). In half of the ªabnormal
projectionsº the entire nerve mistargets, whereas in the
remainder only a subset of axons does. Mistargeting
axons either project past P2 or stop prematurely. Many
of the projections scored as wild type, however, show
abnormal expansion of BN terminus at P2. These guid-
ance defects are unlikely to reflect an indirect conse-
quence of defects in Bolwig's organ differentiation, as
Figure 5. Dscam Disrupts Axon Tracts in the Embryo
organ and cellular morphology in Dscam mutants were
(A±C) The CNS of stage 16 embryos stained with BP102. (A) The
indistinguishable from wild type (data not shown). BNregular ladder-like pattern of stained connectives and commissures
guidance phenotypes in Dscam mutants were similar tois seen in wild type. (B and C) Examples of weak and strong pheno-
types in Dscam mutants, respectively. (B) Projections of the VUM those seen in dock (n 5 246) and Pak (n 5 89) mutants
neurons are abnormal (arrowhead; see [A] for wild type). (C) Disrup- (Figure 6; Table 1). The penetrance of dock and Pak
tion of commissures and irregularities in the thickness of the longitu- were higher (90%±96%) than in Dscam (53%±58%). The
dinal tracts is observed (arrow).
incomplete penetrance of Dscam may reflect residual(D±F) The CNS of stage 16 embryos stained with anti-Fas II
function due to maternal contribution. Alternatively, this(mAb1D4). (D) Continuous staining of three longitudinal axon tracts
(arrow) on either side of the midline is observed in wild type. No may reflect redundancy as we have identified two addi-
FasII-labeled axon bundles cross the midline (white arrowhead). (E tional genes encoding Dscam-related proteins in the fly
and F) Examples of weak and strong phenotypes in Dscam mutants, genome (data not shown).
respectively. (E) The outer two fascicles are disrupted (black arrows)
Dscam RNA is expressed in Bolwig's organ (Figureand abnormal crossing of the midline is observed (white arrows). In
6K) as well as more generally within the CNS and PNS(F), massive disruption in these longitudinal tracts is observed (black
(data not shown). The protein product is exclusively ex-arrow).
pressed on axon processes (see Figures 4D and 4E). To
assess whether expression of Dscam selectively in BN
disrupt axon pathways. Axon tracts in stage 16 embryos was sufficient to rescue the mutant, we constructed a
were visualized with mAbBP102 (Figures 5A±5C) and transgene encoding full-length Dscam driven by the
mAb1D4 (Figures 5B±5D) an antibody to Fasciclin II. In GMR promoter (a strong transcriptional driver providing
wild-type embryos, mAbBP102 stains in a ladder-like Bolwig's organ-specific expression) and introduced it
pattern within the ventral nerve cord, highlighting the into the germline by P element DNA transformation. Two
connectives and commissures. Dscam mutant embryos independent insertions were characterized. In a wild-
exhibit mild (Figure 5B) to severe (Figure 5C) disorgani- type (or a Dscam mutant) background, 100% of the
zation of these tracts. mAb1D4 stains three continuous embryos carrying one or two copies of GMR-Dscam
fascicles on both sides of the midline (Figure 5D). In exhibited strong axon guidance phenotypes (Figures
Dscam, breaks in the connectives, predominantly of the 6L±6O). Individual axons projected in abnormal direc-
outer two fascicles, were observed. Defects exhibited tions over the surface of the optic lobe and rarely con-
variable expressivity (Figures 5E and 5F). In addition, tacted P2 (Figures 6N and 6O). It is unclear whether this
axon bundles aberrantly crossed the midline. These de- reflects sensitivity of BN guidance to increased levels
fects were seen in all embryos of two different heteroal- of Dscam or misexpression in Bolwig's organ of an inap-
lelic combinations (DscamP/Df and DscamE1/Df). propriate isoform (see below), or both. Due to the large
size of the Dscam locus (61 kb), we were unable to
assess whether the wild-type gene rescues the mutantDscam Is Required at a Specific Step in Bolwig's
phenotype. In any case, the dominant phenotype pre-Nerve Axon Guidance
cluded assessing transgene rescue of the mutant phe-To gain insight into Dscam's role in guidance at a defined
notype. In contrast, GMR-dock rescued 85% of dockchoice point for which both Dock and Pak also are re-
quired, we focused on Dscam's role in BN axon guid- mutant embryos (Table 1; Figure 6B).
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Figure 6. Dscam, dock, and Pak BN Axon Guidance Phenotypes Are Similar
(A±H) The BN projection in stage 16 wt and mutant embryos. BN stained with mAb22C10 (brown) and anti-Bsh (black; P2). (A) BN (arrow)
projects with high accuracy to P2 (arrowhead). In Dscam (C and D), dock (E and F) and Pak (G and H) mutant embryos either the entire BN
(C, E, and G) or a subset of axons (D, F, and H) project to ectopic positions (arrows). (B) A dock cDNA specifically expressed in BO by the
GMR driver (see text) rescues the dock mutant phenotype. Genotypes: (C and D) DscamP/Df(2R)cos-2; (E), dockP1/dockP2; (F). dock3/dock3; (G
and H) Pak6/Pak11. For quantitation see Table 1. (I) Schematic represention of the trajectory of the BN. The intermediate target P2 and the
postsynaptic targets (T) in the brain are shown. (J) Indicates mAb22C10 staining showing characteristic rosette shape of Bolwig's organ (bo)
located dorsal to the antennal maxillary complex (amc). (K) Expression of Dscam RNA in bo. (L±O) Overexpression of Dscam leads to a
dominant phenotype in BN pathfinding. (L and N) Low magnification views of BN stained with mAb22C10. (L) In wt, BN forms a tight bundle
through its entire length. (N) In embryos carrying two copies of GMR-Dscam individual axons migrate aberrantly over the surface of the optic
lobe. The position of the bo and the proximal region of the nerve appear normal. (M and O) High-magnification views of the optic lobe region
stained with mAb22C10 (green) and anti-Bsh (red). (M) In wt, BN remains bundled and contacts P2. (O) Most axons mistarget (arrow) and do
not contact P2 in embryos carrying one copy of GMR-Dscam. Scale bars: (A±H), 36 mm; (L and N), 14 mm; (M and O), 8 mm.
Dscam Interacts Genetically with dock and Pak 4%±6% and 10%±13% of embryos heterozygous for
either dock or Dscam, respectively, showed defects.We sought to assess through genetic analysis whether
dock and Pak are functional components of a Dscam Similarly, whereas some 38% of BN were abnormal in
embryos heterozygous for both Dscam and Pak, onlyguidance pathway. Mistargeting defects of BN were ob-
served in some 44% of the embryos heterozygous for 5% were defective in embryos heterozygous for Pak.
The synergistic interactions between Dscam, dock,both Dscam and dock (Figure 7). In contrast, only
Table 1. Quantification of Pathfinding Defects in BN
Complete Partial
Genotype Mistargeting (N) Mistargeting (N) BN Analyzed (N) Mistargeting (%)
DscamE1/Df(2R)EW60 19 22 78 53%
DscamE1/Df(2R)cos-2 28 20 89 54%
DscamP/Df(2R)EW60 20 30 94 53%
DscamP/Df(2R)cos-2 29 22 88 58%
dockP2/dockP1 53 52 109 96%
dock3/dock3 60 66 137 92%
Pak6/Pak11 31 49 89 90%
dockP1/dockP2; pGMR-dock 3 8 74 15%
Complete mistargeting indicates that the entire BN mistargets (see Figures 6C, 6E, and 6G). Partial mistargeting indicates that not all BN
axons mistarget (see Figures 6D, 6F, and 6H).
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Figure 7. Dscam Genetically Interacts with
dock and Pak
Complete mistargeting indicates that the en-
tire BN mistargets. Partial mistargeting indi-
cates that not all BN axons mistarget. Exam-
ples of phenotypes observed are color coded
to match the table. The BN projection was
visualized using mAb22C10 (arrow) and anti-
Bsh (arrowhead). An example of complete
mistargeting is shown for an embryo hetero-
zygous for both Dscam and dock and an ex-
ample of partial mistargeting is shown for em-
bryos heterozygous for Dscam and Pak.
and Pak, the similarity of complete loss-of-function phe- native transmembrane segments share 25% identity.
The Dscam gene extends 61,206 nucleotides from thenotypes, and the physical interactions between these
59 end of exon 1 to the poly(A) addition site in exon 24.proteins are consistent with them acting together to
Alternative forms of exon 4 are tandemly arranged withinmediate recognition between the BN growth cones
6.5 kb of DNA between invariant exons 3 and 5, alterna-and P2.
tive forms of exon 6 within 12.7 kb flanked by invariant
exons 5 and 7, and finally, the entire Ig7 domain is en-
Multiple Forms of Dscam Are Generated coded by alternative exons in 15.7 kb of DNA bracketed
by Alternative Splicing by invariant exons 8 and 10. Alternative exons are
Extensive cDNA analyses revealed alternative amino flanked by conserved splice donor and acceptor sites.
acid sequences for Ig domains 2, 3, 7, and the trans- Regulatory sequences required for DNA rearrangement
membrane domain (Figures 8 and 9). Alternative forms of of sequences in the mammalian immune system were
each Ig domain were used to identify additional related not identified. These observations support the notion
sequences within the gene. This led to the identification that multiple forms of Dscam are generated by alterna-
of a total of 12, 48, and 33 potential alternative se- tive splicing.
quences for Ig2, Ig3, and Ig7, respectively (Figure 9). If alternative exons can be spliced independently, then
Two alternative transmembrane domains also were the Dscam locus potentially encodes 38,016 isoforms.
identified. The N-terminal half of Ig2 is encoded by alter- To gain some additional clues as to the number of alter-
native forms of exon 4, the N-terminal half of Ig3 is native exons used and the variety of different combina-
encoded by alternative forms of exon 6, and the entire tions, we sequenced a panel of 50 cDNAs synthesized
Ig7 domain is encoded by alternative forms of exon 9. by RT-PCR prepared from mRNA isolated from 12±24
Exons are used in a mutually exclusive fashion. That is, hr embryos. Inserts were 1.8 kb in length and spanned
each cDNA sequence contains only one each of the exons 3 through 10. Of these 50 cDNAs, 49 contained
variable exons encoding Ig2, Ig3, and Ig7 and contains unique combinations of variable exons. Representatives
only one of the two alternative transmembrane domains. of 11 of 12 exons 4, 30 of 48 exons 6, and 25 of 33 exons
The protein sequences of alternative exons form highly 9 were found in these cDNAs (Figure 8). Sequencing of
related families (Figure 9): exons 4 share between 33% other cDNAs from embryos and pupae revealed that an
and 81% identity, exons 6 (with the exception of exon additional 1, 6, and 3 alternatives for exons 4, 6, and 9,
6.11) share between 22% and 87% identity, exons 9 respectively, were used (data not shown). These data
suggest that all alternative exons are utilized in vivo.share between 23% and 92% identity, and the two alter-
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Figure 8. Multiple Forms of Dscam Are Generated by Alternative Splicing
(A) The Dscam gene spans 61.2 kb of genomic DNA. Dscam mRNA extends 7.8 kb and comprises 24 exons. Mutually exclusive alternative
splicing occurs for exons 4, 6, 9, and 17. 1 of 12 exon 4 alternatives, 1 of 48 exon 6 alternatives, 1 of 33 exon 9 alternatives, and 1 of 2 exon
17 alternatives are retained in each mRNA, as deduced from cDNA sequence. Variable exons are shown in color: exon 4, red; exon 6, blue;
exon 9, green; and exon 17, yellow. Constant exons are represented by gray lines in genomic DNA and white boxes in mRNA. The splicing
pattern shown (4.1, 6.28, 9.9, 17.1) corresponds to that obtained in the initial cDNA clone from S2 cells. The alternatively spliced exons 4, 6,
9, and 17 encode the N-terminal half of Ig2 (red), the N-terminal half of Ig3 (blue), the entire Ig7 (green), and the transmembrane domain
(yellow), respectively.
(B) Alternative exons are expressed. RT-PCR was performed on total RNA isolated from 12±24 hr embryos. Fifty individual cDNA clones
(numbers 1±50) were isolated and sequenced across exons 4, 6, and 9 (see Experimental Procedures). Alternative exons used in each cDNA
are indicated. Color coding of exons in schematic corresponds to scheme in (A). 49 of the 50 cDNAs contain unique combinations of alternative
exons.
Discussion Through analysis of mutant embryos, we demonstrated
that Dscam is required in BN for pathfinding to an inter-
mediate target. Defects in axonal organization were alsoIn this paper, we identified Drosophila Dscam, pre-
sented evidence that it is a guidance receptor, and re- observed in the central nervous system in Dscam mu-
tants. Several observations are consistent with Dscamported the existence of multiple alternative forms.
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Figure 9. Sequence Alignments of Dscam Variable Domains
Alignments of the amino acid sequences encoded by variable exons 4 (A), 6 (B), 9 (C) and 17 (D). Alternative exons 4, 6, and 9 encode the
N-terminal half of Ig2, the N-terminal half of Ig3, and the entire Ig7, respectively. Alternative exons 17 encode transmembrane domains and
surrounding sequences. Dark shading represents sequence identity. Light shading represents sequence similarity.
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acting as a guidance receptor directly upstream of Dock Dscam and recruit Pak to the membrane. Candidates
for additional components in this signaling pathwayand Pak. First, Dscam and Pak physically interact with
Dock. Second, Dscam, dock, and Pak BN phenotypes have been identified through biochemical and genetic
studies and include a nonreceptor tyrosine kinase, anare similar. And finally, Dscam genetically interacts with
both dock and Pak. adaptor protein linked to actin, and a nonreceptor tyro-
sine phosphatase (Clemens et al., 1996; J. C. C. et al.,Korenberg and colleagues discovered human DSCAM
and proposed that DSCAM trisomy contributes to the unpublished data). A precise mechanistic understand-
ing of the relationship between Dscam, Dock, and Pakpathogenesis in brain development in Down syndrome
patients (Yamakawa et al., 1998). Interestingly, overex- and these additional components will require identifica-
tion of the Dscam ligand and detailed biochemicalpression of Drosophila Dscam selectively in BN leads
to a strong dominant defect in axon guidance. Whether studies.
Does human DSCAM signal through Nck and Pak?this is caused by an increased level of Dscam in the
growth cone or expression of an inappropriate isoform While the extracellular region of human and Drosophila
Dscam share identical domain structures and highly re-remains unclear. It is important to note, however, that
overexpression in this system is likely to exceed the lated amino acid sequences, the intracellular domains
appear unrelated. This may indicate that the human andincreased level of expression associated with trisomy.
That neurons may be particularly sensitive to Dscam fly proteins signal downstream via different pathways
or that the interactions with Nck are mediated by otherdosage is suggested further by the finding that some
10%±13% of embryos heterozygous for Dscam show proline-rich sequences, phosphotyrosine residues or
other associated proteins. Alternatively, there may bedefects in BN axon guidance. Identification of the spe-
cific isoforms normally expressed in BN and the modula- multiple mammalian DSCAM genes, one of which shares
sequence homology with the cytoplasmic domain oftion of these levels may provide further clues as whether
modest increases in Dscam levels promote defects in the fly protein. While a partial sequence of a second
DSCAM-related gene has been identified on humanneural development.
chromosome 11 (accession no. BAA86446), its cyto-
plasmic domain is conserved with human DSCAM andDscam Acts with Dock and Pak to Transmit
is unrelated to Drosophila Dscam.Guidance Signals
We envision that during BN guidance a signal from P2,
an intermediate target, attracts BN growth cones. In Multiple Isoforms of Dscam May Contribute
to Connection Specificitydock, Pak, and Dscam mutants, BN frequently comes
in close proximity to P2 and projects past it or deflects Through sequence analysis of cDNAs, we uncovered
multiple forms of Dscam. These different forms encodeaway from it. Hence, we favor the view that Dscam plays
a prominent role in recognizing a local attractive signal proteins with the same architecture but with sequence
variations in three different Ig domains and the trans-at P2. As the Dscam phenotype in the CNS is more
severe than that of dock (Desai et al., 1999), it is likely membrane domain. Genomic analysis revealed that ex-
ons encoding these alternative domains are tandemlythat Dscam also functions through other downstream
components in other neurons. arranged. There are 12 alternative forms of exon 4 (en-
coding the N-terminal half of Ig2), 48 alternative formsHow might binding of Dscam on a filopodial process
to a ligand at P2 promote attraction? We propose two of exon 6 (encoding the N-terminal half of Ig3), 33 alter-
native forms of exon 9 (encoding Ig7), and 2 alternativealternative models. First, Dock and Dscam may form a
complex in the absence of ligand. This interaction would forms of exon 17 (encoding transmembrane domains).
DNA sequence analysis supports the view that multiplebe mediated by the SH3-1 and SH3-3 domains in Dock
and two closely spaced PXXP sites in Dscam's cyto- forms of Dscam are generated by alternative splicing. If
all combinations are permissible, 38,016 forms of Dscamplasmic tail. Dock's SH3-2 domain may bind to the poly-
proline stretch in the C-terminal tail; this may prevent may be generated. This level of diversity is comparable
to that achieved in individual antibody protein subunitsrecruitment of Pak to the membrane in the absence of
ligand. Upon encountering an attractive ligand at P2, through rearrangement prior to further diversification via
TdT-mediated nucleotide insertion and somatic muta-however, we envision that Dscam becomes tyrosine
phosphorylated. This may promote rearrangement of tion. For instance, it is estimated that in human recombi-
nation generates some 9,180 variable heavy chains (51the complex with Dock binding through its SH2 domain
to phosphotyrosine. This conformational change cannot VH segments, 30 D segments and 6 J segments) (Cook
and Tomlinson, 1995). Our analysis revealed that anstrictly depend upon the SH2 domain, as the SH3-1 and
SH3-3 domains can functionally compensate for the SH2 extraordinary diversity of Dscam isoforms is expressed
during development. As the mechanisms utilized to gen-domain (Rao and Zipursky, 1998). This conformational
change would unmask the SH3-2 domain, thus facilitat- erate splicing of one of two alternative exons, in many
other well-characterized genes, are poorly understooding recruitment of Pak to the complex. Pak, in turn,
would promote actin reorganization and subsequent (Lopez, 1998), it seems premature to entertain models
for the molecular mechanisms regulating the ªeither±orºmovement of the growth cone to P2. Alternatively, in
the absence of ligand the cytoplasmic tail of Dscam may splicing patterns for the 12, 48, and 33 densely packed
alternative exons in Dscam. We have not observed alter-be in a conformation not accessible to Dock binding. In
this model, ligand binding would promote both a confor- native forms of human DSCAM in searches of available
genomic sequences and ESTs. Hence, either alterna-mational change in Dscam's cytoplasmic domain and
tyrosine phosphorylation. Dock may then associate with tively spliced forms of DSCAM are not generated in
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mammals or diversity exists among DSCAM-related for bFGF (Werner et al., 1992). Alternatively, Dscam may
genes. form dimers with other forms of Dscam or act as core-
Several other cell surface proteins involved in neu- ceptors to modulate the activities of other guidance
ronal connectivity or implicated in the process show receptors. In this context, it is interesting to note that
considerable molecular diversity. The vertebrate olfac- Goodman and colleagues (Winberg et al., 1998) have
tory receptors, encoded by a large gene family con- proposed that accurate targeting of motoneurons to
taining in excess of 1000 different sequences, play a key their specific muscle targets requires input from multiple
role in determining glomerular specificity in the olfactory receptor pathways. Future studies will identify proteins
bulb, although they do not appear to be the sole specific- binding to the extracellular domain of Dscam, address
ity determinants (Wang et al., 1998). Multiple forms of whether different forms of Dscam are expressed in spe-
neurexins also have been proposed to play a role in cific neurons, and test the functional importance of di-
synapse specificity (see Missler and SuÈ dhof, 1998). Al- versity.
ternative splicing of neurexins encoded by three differ-
ent genes may give rise to more than a 1000 different Experimental Procedures
isoforms differing in size and amino acid sequence. In
Cell Culture and RNAicontrast to neurexins, all Dscam isoforms share a com-
S2 cells were propagated as previously described (Clemens et al.,mon domain architecture. While loss-of-function studies
1996). A cDNA encoding a histidine-tagged (63 histidine) SH2 do-have not yet critically addressed the role of neurexins
main (S2HisSH2) of Dock was inserted into pAT-Hygro, transfected into
in forming neuronal connections, their localization to S2 cells, and selected (Herbst et al., 1996), producing the S2HisSH2
synapses makes them intriguing candidates for contrib- cell line. For RNAi, a PCR fragment (700 bp) containing coding
uting to connection specificity. sequence for Dscam was used to produce double-stranded RNA
as described (Clemens et al., 2000).Two cadherin cell adhesion molecule subfamilies con-
taining multiple forms also have been implicated in spec-
Purification of p270ificity (for review see Uemura, 1998). There are some 20
S2HisSH2 cells (6 3 1010) were harvested by centrifugation and sus-different classic cadherins expressed in mammals. They
pended in lysis buffer (100 ml; 50 mM Tris, pH 8.0, 500 mM KCl,
are localized to synapses and, in some cases, show 150 mM NaCl, 2 mM sodium vanadate, 10 mM NaF, 1% NP-40,
restricted patterns of expression correlating with spe- 10% glycerol, 10 mM imidazole, 13 complete EDTA-free protease
cific functional pathways (Takeichi et al., 1997; Shapiro inhibitors [Roche]). Cells were lysed using a PT-2000 polytron (Kine-
matica). The lysate was cleared by centrifugation (27,000 3 g), andand Colman, 1999). Recently, a second family of cadher-
incubated with gentle rocking with Ni-Agarose in lysis buffer (7 ml).ins, cadherin-related neuronal receptors (CNRs), was
The resin was washed with lysis buffer (3 3 40 ml), lysis bufferidentified in mice through a protein interaction screen
lacking KCl (2 3 40 ml), and eluted (7.5 ml; low salt buffer plus 200
and were shown to be expressed at synapses (Kohmura mM imidazole). SDS (800 ml; 10%) was added to the eluent and
et al., 1998). Fifty-two different forms of CNRs have boiled (5 min). RIPA buffer (80 ml) (Clemens et al., 1996) lacking
been identified in three different clusters in the human SDS was added to the boiled eluate and incubated (16 hr) with 4G10
anti-phosphotyrosine resin (1 ml). 4G10 resin was washed with RIPAgenome (Wu and Maniatis, 1999). The mRNAs encoding
buffer (10 ml; including SDS) followed by 100 mM triethylamine (TEA)the mouse CNRs are expressed in a diffuse and rather
(10 ml; pH 8.0). Proteins were eluted in TEA (10 ml; pH 11.5). Elutedgeneral pattern within the nervous system. In the olfac-
proteins were dried, dissolved in SDS-PAGE loading buffer (20 ml),tory bulb, two different CNRs were shown to be coex-
boiled (5 min), and separated by SDS-PAGE (7.5%). A p270 band
pressed in a single neuron while a smaller fraction of was visualized by Coomassie staining, excised for tryptic digestion,
neurons expressed only one or the other CNR. This and microsequenced (Harvard Microchem).
raises the intriguing possibility that different combina-
tions of CNRs in different neurons could impart connec- Molecular Analysis of Dscam
EST clones were obtained from the Berkeley Drosophila Genometion specificity (Serafini, 1999). Given the conservation
Project (BDGP). Other cDNA clones were obtained from variousbetween guidance receptors in flies and mammals, it is
cDNA libraries. cDNA sequences were aligned to a DNA contigsurprising that CNRs were not identified in the recently
from Celera and BDGP using the BDGP BLAST server. Additionalpublished DNA sequence of the Drosophila genome (Ru-
sequence analysis was done using MacVector ClustalW alignments
bin et al., 2000). While it is still unclear whether DSCAM- (Oxford Molecular Group) and a splice site prediction program
related genes in mammals may be alternatively spliced, (BDGP). Details available upon request. To obtain clone sequences
different organisms may have evolved different strate- reported in Figure 7B, reverse transcription was performed on total
RNA isolated from 12±24 hr embryos. First strand synthesis wasgies to generate diversity among related guidance re-
primed using an exon 11 primer. PCR was performed using primersceptors, as a means of specifying complex patterns of
from exons 3 and 11. A 2.4 kb product was cut with BamHI andneuronal connectivity.
cloned into pBluescript (Stratagene). Individual clones were isolatedTo our knowledge, the massive use of alternative ex-
and sequenced using T7 and T3 primers and an internal primer in
ons in a combinatorial fashion to generate thousands exon 7.
of different protein isoforms all sharing a common archi-
tecture with differences in amino acid sequence is un- Characterization of Interactions between Dscam and Dock
precedented within the nervous system. The physiologi- The small-scale purification procedure of SH2-associated proteins
was a modified version of the large scale purification (see above).cal importance of these different isoforms remains
Immune precipitation from embryos and S2 cells was carried outentirely unclear. Diverse forms of Dscam may recognize
essentially as previously described (Clemens et al., 1996). Gel-over-distinct isoforms of specific ligands. That such alter-
lay analysis was performed by radiolabeling recombinant GST-
ations could lead to changes in ligand±receptor interac- DockSH2, probing, and washing essentially as described (Margolis
tion are supported by the findings that alternative forms and Young, 1995). Dock binding experiments with proteins tran-
of Ig repeats in murine FGF receptor 1, generated by scribed and translated in vitro were a modified version of Tang et
al. (2000). Mutations were introduced into the cytoplasmic domainalternative splicing, exhibit marked differences in affinity
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of Dscam using the QuikChange Site-Directed Mutagenesis Kit from Clemens, J.C., Worby, C.A., Simonson-Leff, N., Muda, M., Maehama,
T., Hemmings, B.A., and Dixon, J.E. (2000). Use of double-strandedStratagene. Primers were designed to change P1685 and P1686 into
RNA interference in Drosophila cell lines to dissect signal transduc-leucines in P1L and P1,2L, while P1727 and P1728 were changed to
tion pathways. Proc. Natl. Acad. Sci. USA, in press.leucine and threonine, respectively, in P2L and P1,2L.
Cook, G.P., and Tomlinson, I.M. (1995). The human immunoglobulin
Yeast Two-Hybrid Assay VH repertoire. Immunol. Today 16, 237±242.
Yeast two-hybrid assays were performed as previously described Culotti, J.G., and Merz, D.C. (1998). DCC and netrins. Curr. Opin.
(Hing et al., 1999). The Dscam cytoplasmic domain (aa 1657±2016), Cell Biol. 10, 609±613.
the C-terminal part of the cytoplasmic domain (aa 1817±2016), and
Desai, C.J., Garrity, P.A., Keshishian, H., Zipursky, S.L., and Zinn,various mutant forms were fused to the yeast Gal4 activation domain
K. (1999). The Drosophila SH2-SH3 adapter protein Dock is ex-
(pGAD424). b-galactosidase activity (Miller units) was represented
pressed in embryonic axons and facilitates synapse formation by
qualitatively: 2, less than 1 unit; 1, 1±10 units; 11, 11±20 units;
the RP3 motoneuron. Development 126, 1527±1535.
11111, more than 40 units.
Flanagan, J.G., and Vanderhaeghen, P. (1998). The ephrins and Eph
receptors in neural development. Annu. Rev. Neurosci. 21, 309±345.Genetics
Fujita, S.C., Zipursky, S.L., Benzer, S., Ferrus, A., and Shotwell,For description of dock and Pak mutations, see Garrity et al. (1996)
S.L. (1982). Monoclonal antibodies against the Drosophila nervousand Hing et al. (1999). For deficiencies and mutations of the 43B
system. Proc. Natl. Acad. Sci. USA 79, 7929±7933.region see Heitzler et al. (1993). The P element insertion in DscamP
was mapped by sequence analysis of a plasmid rescue fragment Garrity, P.A., Rao, Y., Salecker, I., McGlade, J., Pawson, T., and
(O'Kane, 1998). Polytene chromosomes from wild-type, Df(2R)CA68/1, Zipursky, S.L. (1996). Drosophila photoreceptor axon guidance and
and Df(2R)drl21/1 larvae were used for in situ hybridization (Pardue, targeting requires the Dreadlocks SH2/SH3 adapter protein. Cell 85,
1994). Bolwig's organ±specific expression of Dscam was achieved 639±650.
by inserting a full-length Dscam cDNA (containing alternative exons Goodman, C.S., and Shatz, C.J. (1993). Developmental mechanisms
4.1, 6.30, 9.30, and 17.2) into the pGMR transformation vector and that generate precise patterns of neuronal connectivity. Cell Suppl.
introducing into the germline by P element transformation. Two 72, 77±98.
lines, one with an insertion on the X and the other on the second Guthrie, S. (1999). Axon guidance: starting and stopping with slit.
chromosome, were analyzed. Expression of the Dscam protein in Curr. Biol. 9, R432±R435.
these lines was confirmed by anti-Dscam antibody staining. To as-
Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Sciencesess rescue, homozygous embryos from the cross dockP1/CyO GFP;
279, 509±514.pGMR-dock and dockP2/CyO GFP were analyzed for BN defects as
Heitzler, P., Coulson, D., Saenz-Robles, M.T., Ashburner, M., Roote,described in results.
J., Simpson, P., and Gubb, D. (1993). Genetic and cytogenetic analy-
sis of the 43A-E region containing the segment polarity gene costalImmunohistology
and the cellular polarity genes prickle and spiny-legs in DrosophilaPrimary antibodies used for immunohistochemistry were: rabbit
melanogaster. Genetics 135, 105±115.anti-Dscam (1:300); mAb22C10 (Fujita et al., 1982; 1:50); guinea pig
Herbst, R., Carroll, P.M., Allard, J.D., Schilling, J., Raabe, T., andanti-Bsh (1:750); rabbit anti b-galactosidase (Cappel; 1:1000); rabbit
Simon, M.A. (1996). Daughter of sevenless is a substrate of theanti-KruÈ ppel (Hoch et al., 1994; 1:500); mAb BP102 (Seeger et al.,
phosphotyrosine phosphatase Corkscrew and functions during sev-1993; 1:10); and mAb 1D4 anti-Fas II (Van Vactor et al., 1993; 1:50).
enless signaling. Cell 85, 899±909.Immunohistochemistry and mounting of embryos were carried out
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analyzed using a Bio-Rad MRC 1024 confocal microscope. In situ Pak functions downstream of Dock to regulate photoreceptor axon
hybridization of Dscam was achieved using DIG-labeled riboprobes guidance in Drosophila. Cell 97, 853±863.
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fates in a single cell are established by the neurogenic cascade in
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